Novavax Vaccine Looked Good During the FDA Committee Meeting
Novavax COVID Vaccine looked good to me during the FDA's VRBPAC meeting. Let's review their data. Keep an eye on their univalent and bivalent vaccine efficacy.
If you like this content and want more, I am doing a special lifetime membership offer. Click here:
[ Ссылка ]
Want to support this work?:
Buy me a coffee :-) [ Ссылка ]
Become my patron: [ Ссылка ]
PayPal: [ Ссылка ]
My substack: [ Ссылка ]
#drbeen #koolbeens #COVID
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Wednesday, Jun. 29 2022
My talks about Novavax:
Playlist of my talks on Novavax COVID Vaccine
[ Ссылка ]
Individual talks:
Feb 2022 [ Ссылка ]
Nov 2021 [ Ссылка ]
Oct 2021 [ Ссылка ]
Oct 2021 [ Ссылка ]
Oct 2021 [ Ссылка ]
Sep 2021 [ Ссылка ]
July 2021 [ Ссылка ]
Jun 2021 [ Ссылка ]
March 2021 [ Ссылка ]
Jan 2021: [ Ссылка ]
The Novavax vaccine against COVID-19: What you need to know
[ Ссылка ]
COVID-19 Press Releases | Novavax
[ Ссылка ]
Novavax Investor Relations - Press releases & statements
[ Ссылка ]
Novavax COVID-19 Data Presented at FDA VRBPAC Meeting Demonstrates Broad Antibody Responses to Both Prototype and Omicron-Specific Variants - Jun 28, 2022
[ Ссылка ]
Novavax Investor Relations - Events & presentation
[ Ссылка ]
novavax-vrbpac-28jun2022
[ Ссылка ]
